New research finds nearly a third of melanomas found during skin checks may not be harmful, improving treatment options
Melanoma is among the most commonly diagnosed cancers in Australia.
Cancer in the News
Feature Articles
Study finds a link between aging and cancer metastases
Spreading cancer cells that escape a primary tumor site can seed in tissues distant from the tumor, but may take several years or decades to grow into full metastatic cancers.
Posted in Melanoma News, Health Professionals, Of Interest
InterVenn Biosciences Announces New Data Validating the Clinical Performance of DAWN™ IO Melanoma as a Novel Liquid Biopsy Test to Improve Assessment of Benefit to Cancer Patients
SAN FRANCISCO–(BUSINESS WIRE)–InterVenn® Biosciences, a clinical technology company leveraging glycoproteomics to transform the future of healthcare, today announced new data showing that its new DAWN IO Melanoma test accurately assesses and classifies advanced melanoma patients as likely or unlikely to benefit from immune checkpoint inhibitor therapies: either pembrolizumab alone or ipilimumab in combination with nivolumab.
Posted in Melanoma News, Health Professionals, Clinical Trials
10 Factors That Will Shape the Future of Skin Cancer Treatment
Will drinking caffeinated coffee reduce skin cancer risk? Is gene expression profiling set to become mainstream testing for melanoma? See what Darrell S. Rigel, MD, MS, FAAD, has to say.
Posted in Melanoma News, Health Professionals, Of Interest
 |
 |
 |
 |
